Date Filed | Type | Description |
05/25/2023 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.
Txns:
| Granted 960 shares
@ $11.71, valued at
$11.2k
Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2022 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.
Txns:
| Sold 7,955 shares
@ $18.7746, valued at
$149.4k
Sold 4,414 shares
@ $19.3595, valued at
$85.5k
|
|
11/28/2022 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.
Txns:
| Sold 861 shares
@ $21.3765, valued at
$18.4k
Sold 397 shares
@ $21.9914, valued at
$8.7k
|
|
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/19/2021 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.
Txns:
| Granted 10,000 shares
@ $0 |
|
11/17/2021 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.
Txns:
| Granted 233 shares
@ $50.99, valued at
$11.9k
|
|
05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2020 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.
Txns:
| Granted 291 shares
@ $45.45, valued at
$13.2k
|
|
05/19/2020 |
4
| Schwarzer Fred (CEO and President) has filed a Form 4 on IGM Biosciences, Inc.
Txns:
| Granted 1,096 shares
@ $13.6, valued at
$14.9k
|
|
02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/17/2019 |
3
| Schwarzer Fred (CEO and President) has filed a Form 3 on IGM Biosciences, Inc. |